FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: DETERMINATION THAT FOUR HEPARIN SODIUM IN SODIUM CHLORIDE IN PLASTIC CONTAINER (HEPARIN SODIUM) DRUG PRODUCTS WERE NOT WITHDRAWN FROM SALE FOR REASONS OF SAFETY OR EFFECTIVENESS

WASHINGTON, Aug. 26 -- Food and Drug Administration has issued a notice called: Determination That Four Heparin Sodium In Sodium Chloride In Plastic Container (Heparin Sodium) Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness.

The notice was published in the Federal Register on Aug. 26 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA or Agency) has determined that HEPARIN SODIUM 12, 500 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER (heparin sodium) injectable, 5, 000 units/100 milliliters (mL); HEPARIN SODIUM 25, 000 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER (heparin sodium) injectable, 5, 000 units/100...